Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Human infection with Eurasian avian-like influenza A(H1N1) virus, China.

Wang DY, Qi SX, Li XY, Guo JF, Tan MJ, Han GY, Liu YF, Lan Y, Yang L, Huang WJ, Cheng YH, Zhao X, Bai T, Wang Z, Wei HJ, Xiao N, Shu YL.

Emerg Infect Dis. 2013 Oct;19(10):1709-11. doi: 10.3201/eid1910.130420. No abstract available.

2.

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China..

N Engl J Med. 2009 Dec 24;361(26):2507-17. doi: 10.1056/NEJMoa0906612.

3.

Clinical features of initial cases of 2009 pandemic influenza A (H1N1) in Macau, China.

Zhou BT, Fan YM, Li TM, Liu XQ.

Chin Med J (Engl). 2010 Oct;123(19):2651-4.

4.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H; Japanese Influenza Collaborative Study Group..

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003.

PMID:
19962344
5.

Pandemic (H1N1) 2009, Shanghai, China.

Shen Y, Lu H.

Emerg Infect Dis. 2010 Jun;16(6):1011-3. doi: 10.3201/eid1606.090991.

6.

Epidemiological and clinical features of 308 hospitalized patients with novel 2009 influenza A (H1N1) virus infection in China during the first pandemic wave.

Zhang G, Xia Z, Liu Y, Li X, Tan X, Tian Y, Liang L, Nie G, Zhou B.

Intervirology. 2011;54(3):164-70. doi: 10.1159/000319930.

PMID:
21051903
7.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004.

PMID:
21767571
8.
9.

Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.

Charlier C, Enouf V, Lanternier F, Grandadam M, Amazzough K, Blanche S, Lecuit M, Lortholary O, van der Werf S.

Clin Microbiol Infect. 2009 Dec;15(12):1189-91. doi: 10.1111/j.1469-0691.2009.03007.x.

10.

Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.

Saito R, Sato I, Suzuki Y, Baranovich T, Matsuda R, Ishitani N, Dapat C, Dapat IC, Zaraket H, Oguma T, Suzuki H.

Pediatr Infect Dis J. 2010 Oct;29(10):898-904. doi: 10.1097/INF.0b013e3181de9d24.

PMID:
20442686
11.

Community transmission of pandemic influenza A (H1N1) in China.

Liu W, Jiang T, Li XF, Tang F, Wei MT, Yu M, Zhao H, Yu XD, Liu LJ, Qin CF, Cao WC.

Infect Control Hosp Epidemiol. 2010 Sep;31(9):961-3. doi: 10.1086/655020.

PMID:
20636129
12.

Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S.

J Infect. 2009 Sep;59(3):207-12. doi: 10.1016/j.jinf.2009.07.002.

PMID:
19619898
13.

Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.

Couturier BA, Bender JM, Schwarz MA, Pavia AT, Hanson KE, She RC.

Influenza Other Respir Viruses. 2010 Jul;4(4):199-204. doi: 10.1111/j.1750-2659.2010.00144.x.

14.

Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.

Ryoo SM, Kim WY, Sohn CH, Seo DW, Oh BJ, Lee JH, Lee YS, Lim KS.

Influenza Other Respir Viruses. 2013 Sep;7(5):833-7. doi: 10.1111/irv.12065.

15.

Lessons from the epidemiological surveillance program, during the influenza A (H1N1) virus epidemic, in a reference university hospital of Southeastern Brazil.

Moretti ML, Sinkoc V, Cardoso LG, Camargo GJ, Bachur LF, Hofling CC, Angerami R, Trabasso P, Garcia MT, Resende MR.

Rev Soc Bras Med Trop. 2011 Jul-Aug;44(4):405-11.

16.

Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.

Malato L, Llavador V, Marmier E, Youssef J, Balick Weber C, Rozé H, Bessede E, Fleury HJ.

Euro Surveill. 2011 Jan 27;16(4). pii: 19776.

17.

Abnormal liver chemistry in patients with influenza A H1N1.

Yingying C.

Liver Int. 2011 Jul;31(6):902. doi: 10.1111/j.1478-3231.2011.02519.x. No abstract available.

PMID:
21645222
18.

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.

Kawai N, Ikematsu H, Kawashima T, Maeda T, Ukai H, Hirotsu N, Iwaki N, Kashiwagi S.

Influenza Other Respir Viruses. 2013 May;7(3):448-55. doi: 10.1111/j.1750-2659.2012.00421.x.

19.

Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.

Yi H, Lee JY, Hong EH, Kim MS, Kwon D, Choi JH, Choi WY, Kim KS, Lee JK, Oh HB, Kang C.

Emerg Infect Dis. 2010 Dec;16(12):1938-42. doi: 10.3201/eid1612.100600.

20.

Contribution of the Portuguese Laboratory Network for the Diagnosis of Influenza A(H1N1)pdm09 infection during the 2009/10 and 2010/11 influenza seasons.

Portuguese Laboratory Network for the Diagnosis of Influenza Infection..

Euro Surveill. 2012 Jul 5;17(27). pii: 20211.

Items per page

Supplemental Content

Support Center